Open Access Policy
Open access mainly refers to the practice of making peer-reviewed scholarly research and literature freely available online to the individuals, who are interested in reading it without any limitation. Our OAJBS publications are absolutely free and always available online to anyone with internet access. If any author/editor attributes to unrestricted use, reproduction and distribution in any medium then it is permitted to access that particular article. More information can be found at Open Access.
Open Access Journal of Biomedical Science (OAJBS) has a legal responsibility to ensure that its journals do not publish material that interfere with copyright or includes slanderous content. Manuscripts containing material that invades copyright or is potentially unfounded data will be rejected. Corresponding Author is responsible for all author for the compilation for copyright assignment. For readers it is free to read, share, download these articles for intellectual/research purposes as it is an open access journal. However, they will not copy blindly and copyrighted material in their work/manuscript/paper/lecture/seminar. Any reference from these manuscripts should be properly approved, or prior permission should be taken from the copyright holder. The publisher or any other party does not hold the copyright for the manuscripts.
CC BY License
In Open Access Journal of Biomedical Science (OAJBS) we ask that authors enter their funding status during the manuscript/article submission. We can use that information to determine whether it may be a CC BY NC license is mandated. Any subsequent reuse or distribution of content licensed under CC BY NC must maintain attribution for an author(s) and the published article's title, journal citation, and DOI. OAJBS follows the Creative Commons Attribution License and All the works published in OAJBS are under the terms of the Creative Commons Attribution License. Our journal follows CC-BY-NC licence.
OAJBS accomplice with- creative common licence [CC BY NC 4.0]
'CC' stands for Creative Commons license. 'BY' symbolizes that user have provided acknowledgement to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and ‘NC’ stands for Non-Commercial. We have observance like it is having permission to read and write, permission to translate, commercial uses for manuscript.
Publication of articles in Open Access Journal of Biomedical Science (OAJBS) involves article processing charges/Fees will be paid by research funding institutions or the by the authors themselves from their own pocket. This processing fees includes manuscript peer-reviewing, formatting of an article, editing an article, publishing, archiving, DOI and other maintenance costs will be associated with the production and publication of the article charges/Fees. Under some circumstances Article Processing charge can be waived off up to 50% for the author (If author is from low income or developing nation). The author should pay the publication fees/charges by PayPal/ Credit Card Authorization form. Publication charges will be based by country wise. For more information click here
Defined by WAME, editorial freedom means that the Editor(s) has/have complete authority over the entire editorial content of their journal and the timing of the publication of that content. Our Open Access Journal of Biomedical Science Board members have full liberty to control the process for manuscript subscription evaluation, along with the content published in any other journal. There will be no changes or interfering with our Board Members in the final decisions.
Peer Review Policy
Peer Review Process refers to a system, which is used to access Manuscript quality before it is published online. All the independent researchers/experts/professionals in the relevant field are subjected to assess the submitted manuscripts for validity, originality, and significance to help editors determine whether a manuscript should be published in their journal.
Peer Review Method
Our Open Access Journal of Biomedical Science follows Double-blind peer review process, in which both the editors and authors who are going to review the articles submitted and approve for publication are completely unaware of each other’s identity. Moreover, our Editorial Manager of Editor Department assigns the articles, which are received from the researchers to the reviewers/editors along with an electronic review form in which the reviewers are initially supposed to check the scope of the manuscript whether fits to the journal or not then, they need to fill the form of a questionnaire and at the end they will provide their comments or any suggestions/edits in the paper (if required) to approve the manuscript for publication in the journal. If a paper/article is rejected, this does not necessarily mean it is of poor quality and it may be rejected it doesn't meet the high standards of originality and novelty as per the guidelines. The journal will get publish if the reviewer suggests only minor edits but before that, the author is asked to make those corrections.
Authorship states that an author must contribute considerably to a work’s: concept or design; data collection, analysis or explanation; academic content development or critical review; final version approval; and integrity, ensuring that issues related to the precision or completeness of any part of the work are properly investigated and resolved. Our assessment approves the authorship criteria defined by ICMJE. Individuals who meet the following criteria can be classified as authors.
In OAJBS all the authors should contact through email from the submission till the publishing of an article. If any issues are related to authors, it should be resolved/discuss before the manuscript is published in a Journal. If authors have any changes/requirements in article only corresponding author is responsible for the entire process. If article is once submitted, it cannot be changed for all the contributors.
The corresponding author is responsible for associating who meets these criteria should ideally do this when preparing the work, and he/she should make revisions as appropriate as the work progresses. It is the collective responsibility of all authors, not the journal to which the work is submitted, to fix that all people named as authors meet all four criteria; it is not the role of journal editors to determine who qualifies or does not qualify for authorship or to arbitrate authorship conflicts. If agreement cannot be reached about who qualifies for authorship or the order of authors, the institution(s) where the work was performed, not the journal editor, should investigate. Authorship disputes will often need to be referred to institutions if the authors cannot resolve the dispute themselves.
Procurement of funding, collection of data, or overall guidance of the research group alone does not usually justify authors. All contributors who will support for an article will also be listed in acknowledgement.
Conflicts of Interest
In Open Access Journal of Biomedical Science (OAJBS) if manuscript has been submitted it must include a ‘conflict of interest’ section at the end of the manuscript. If funding is not available from the author's institution, this should be specified upon submission only. If authors working on any sponsored clinical trials or publications, should declare such works under conflict of Interest during submission.
The Submission of Clinical Trials
The clinical trial as described by ICMJE is supported by OAJBS. Any study that prospectively assigns individuals or a group of individuals to an intervention, with or without parallel comparison or control groups, in order to examine the relationship between a health-related intervention and a health result is referred to as a clinical trial. Drugs, surgical procedures, gadgets, behavioral treatments, educational programs, nutritional interventions, quality improvement interventions, and process modifications are a few types of interventions used to influence a biological or health-related outcome. Health outcomes include pharmacokinetic measurements and adverse events as well as other biological or health-related measurements taken from patients or participants.
Authors has to provide the proper literature details of where he/she inspired, or the previous works related to the current topic or research. Authors must cite appropriate literature to support any statement that relies on external sources of information in their articles.
The articles submitted by authors must contain a minimum of 80% unique content verified by PlagScan Software(Which should be unique and must not copy from any other web sites). The authors must maintain 100% uniqueness in the Results and conclusion part of the text. We will resend the articles, which have below 80% uniqueness to the authors for revision and asked for resubmissions with uniqueness (as per guidelines).
Our OAJBS publish only unpublished articles only, our journal does not allow to articles which are published in any other platform. If the article has published in other language author must mention in the cover letter. If authors using their past works, they have to provide a proper citation to it and they have to clearly state how the article is different from their past work. If author want to reuse the past work figures or considerable amounts of content, he/she must have to get a authorization from the original author and the authors are responsible for getting this. Our journal will consider the following omissions if acceptable and made transparent upon submission.
Publishing the article from the preprint servers or authors personal website(institute/Blog) does not consider as previously published.
A PhD thesis or other academic thesis, including those made available to the public in accordance with the specifications of the organisation conferring the qualification.
Results of clinical trials summarized for public registries
Clinical trial summary results posting in publicly accessible databases is typically not regarded as duplicate publication. Clinical trial writers must register their trial in a suitable accessible registry in order to submit their manuscript to OAJBS.
Meeting abstracts or posters may be published in Open Access publications prior to the submission of the complete contribution. These abstracts must be referenced in their submission as well as in the cover letter that goes with the manuscript.
Our Journal allow to publish the articles which are in other languages which have been precisely translated from an original publication under the Editor's decision. Journals should make sure they have the necessary authorization from the original journal/publisher before they translate and publish content that has already been published somewhere else. They must clearly state that the content has been translated and republished under the CC BY licence and must cite the original author of the content.
Our journal follows the synopsis of misconduct provided by WAME.
a) Misrepresentation of data: Includes fabrication, misleading selective reporting of conclusions, exclusion of contrary evidence, and purposeful suppression and/or modification of data.
b) Plagiarism: The use of another person's words, concepts, or ideas without giving due credit to the original author and representing them as one's own creative work.
c) Improper authorship: Unauthorised assignment of credit, such as excluding others, misrepresenting the same content as original in multiple publications, listing people as authors who did not significantly contribute to the published work, or submitting multi-authored publications without the consent of all authors, are all examples of improper authorship.
d) Misuse of other's ideas: The interchange of ideas among colleagues is a crucial component of intellectual endeavour. When studying grant proposals and articles, scholars can pick up fresh ideas from other people. However, misusing this information may result in fraud. It is improper to take such substance in large quantities
e) Violations of commonly accepted research methods: A major departure from recognised procedures while proposing or conducting research, incorrect experiment manipulation to produce biased results, deceptive statistical or analytical manipulations, or improper reporting of data. The use of funding, the treatment of animals, human subjects, recombinant products, novel equipment, or radioactive, biologic, or chemical materials are only a few examples of serious or significant, repetitive, purposeful violations of local laws and regulations that have an impact on research.
f) Dual publication: The simultaneous submission of a work to multiple journals in the same or different languages.
Mistakes are a component of science and publishing, and ICMJE Recommendations state that when they are discovered, they must be corrected and published. It is our duty to fix typographical mistakes in previously published publications. In this situation, the corrections will be published in accordance with the following rules:
Once significant mistakes are identified, corrections will be issued as quickly as feasible.
Corrections must provide a thorough description of the changes made as well as a link to the source articles.
The originally published version won't be taken out of circulation. To alert readers that this article has been corrected, a link to it will be posted beside the original version, along with a brief note.
Depending on the article's stage of publication, the correction's format may vary. Corrections can be made directly online for current issue articles that have already been published on an early view service (or an equivalent). In these situations, it is necessary to include an audit trail that details the modifications that have been made to the article's online version since it was first published, along with the date that each change was made.
A similar correction statement should be written for any articles that have already been published in an issue, and it should link back to the original piece. Normally, the edits in these situations shouldn't be made directly to the article.
Rarely, articles that have already been published may be withdrawn. According to OAJBS, the purpose of retractions is not to punish writers but rather to update the literature and inform readers of any papers that may have significant flaws or incorrect data, leading to questionable conclusions. Please take note that while articles will be retracted, they will not be removed from the public domain. There will be case-by-case discussion of each retraction. They have convincing proof that the results are inaccurate, either due to significant inaccuracy (such as a computation or experimental error) or due to fabrication or falsification of data (such as picture manipulation)
It contains plagiarism
The results have already been reported elsewhere without adequate citation of the original sources, editor disclosure, permission to republish, or justification (redundant publication)
It contains information or content that is not properly licenced
There has been a copyright violation or there is another major legal issue (such as libel or privacy)
It presents research that is inappropriate
It was only accepted for publication after a flawed or skewed peer review procedure
The author(s) failed to disclose a significant competing interest or conflict of interest that, in the editor's opinion, would have adversely affected editorial decisions or peer reviewer recommendations.
Retractions will be made public in accordance with the following rules
All electronic versions of retractions should contain links to the retracted articles
Retraction titles must make it clear that they are retractions
The title of the retracted work, the exact justification for retraction, the author(s), and any pertinent information should all be included in the retraction.
Retractions must be released as quickly as feasible to lessen their negative effects.
Prior Communication to Publication
When a study is debated in the media, we think it's critical that the peer-reviewed, published version be accessible so that the press may make defensible judgments based on it. In response to inquiries from the media over a preprint or conference presentation, authors may explain or clarify the work or provide details about its background. In these cases, media attention won't get in the way of how the contribution is handled editorially. Additionally, we advise writers to be explicit if the manuscript hasn't yet completed peer review, the results are preliminary, and the conclusions are subject to change.
When they discover flaws and ethical concerns in the articles that have been published, readers, writers, and organisations are invited to notify the editorial office. With the assistance of Academic Editors, the Editorial Board, or Reviewers, the editorial office will carefully examine and address this issue and may opt to publish a Correction or Retraction to the published article. Additionally, readers are urged to write a Commentary or Letter to the Editor on the items that have been published, submit their criticism to the editorial office, and have those submissions examined. These submissions will provide readers' reflections and discussions.
Authors are allowed to post preprints of the Original Version, Accepted Manuscript, and Version of Record on preprint servers, authors' or institutional websites, and open forums for discussion between researchers on preprint commenting websites or community preprint servers. When submitting their work, authors who choose to make it available as a preprint should specify the preprint server and include the DOI or accession number. Once accepted, the manuscript will be made freely available online as soon as it is published. Authors must update all preprint server records with a journal reference (with DOI) and a link to the article's online version once it has been published.
Appeals and Complaints
During the editorial process, authors have the right to challenge editorial judgments or review reports. To submit your appeals, kindly get in touch with the editorial department of the specific journal. After carefully reviewing the editorial process and decision-making, editors should let appeals to override earlier choices (for example, additional factual input by the authors, revisions, extra material in the manuscript, or appeals about conflicts of interest and concerns about biased peer review). During the peer-review process, editors should act as a mediator in all conversations between authors and peer reviewers. Editors may request feedback from additional peer reviewers before making a final choice. Following an appeal, the editor's decision is final. The author's complaint alone shouldn't sway judgement. The editor in charge of the journal will deal with complaints about the editorial procedure or publication ethics if they are submitted to the editorial office of the journal. Please email the publisher at email@example.com if the editor is engaged in your complaints.